COVID-19: -

Our Commitment to Client Service & Investor Communications

19: Investing in therapeutic development | Sunil Shah of o2h Ventures

23 Feb 2021 / Podcast Tax Enhanced

By Dr Brian Moretta

Although investing in drug development would seem to be ideal for EIS investment, it has been a somewhat niche area. Sunil Shah is hoping to change that, with o2h Ventures having recently launched the UK's first Knowledge Intensive Fund focused on this area.

Sunil gives a great perspective on how investing in the industry has evolved over the last couple of decades, and how these changes work in the favour of early-stage investors. We also talk about the challenges of investing in this area, where specialist knowledge is needed and how the growth in private capital has affected the industry.

Any discussion in this area can’t ignore COVID and we also talk about how the industry has been rising to the challenge.

Please email enquiries@hardmanandco.com if you have any questions or comments on The EIS Navigator.

Never miss an episode – click here to subscribe to The EIS Navigator on most popular services. 

Listen now

Sunil Shah

o2h Ventures o2hventures.com
o2h Chai Time webinars youtube.com/channel/UC7YqoMJ566H7uau0E2WC3Qw
UK BioIndustry Association guide to investing in the UK biotech sector www.bioindustry.org/policy/invest-in-biotech.html